
About
Evercyte GmbH develops human cell-based models and extracellular vesicle products for preclinical testing, drug screening, and biotechnology applications. It also provides cell line development, assay-ready cells, and EV-related services for researchers and companies working with human-relevant in vitro systems. The company is based in Vienna, Austria.
Services
Cell line development
Develops primary cells into immortalized, reprogrammed, or assay-ready cell lines and can source tissue, isolate primary cells, and characterize cell phenotype and bioassays.
Drug screening
Tests compounds for cytotoxic, senolytic, anti-fibrotic, neo-angiogenic, wound healing, and cytokine-targeting effects using human-relevant cell cultures.
Extracellular vesicles
Provides EV-related services including EV enrichment, purification, characterization, potency testing, and production from telomerized or customer-derived cells.
Gene editing studies
Offers gene editing-related studies as part of its service portfolio.
- What to send
- Primary cells to be immortalized
- Shipping/billing address
- Information on cell type / source
- Donor specifications
- Information on in vitro culture
- Primary cells derived from customer, if applicable
4 more
- Information on compound(s) to be tested
- Customer name, organization, affiliation, email, phone number, shipping/billing address, and comments/questions for pers
- Cell type/source, donor specifications, cell type characteristics, and in vitro culture information for immortalization
- Primary cells derived from customer, with ethical approval status and related culture, biosafety, sterility, STR, and vi
Capabilities
- Assays and studies
- Cytotoxicity
- Proliferation
- Cytokine targeting
- Senolytic activity
- Senomorphic activity
- Anti-fibrotic activity
14 more
- Neo-angiogenic potential
- Wound healing activity
- 2D proliferation assay
- 3D sprouting assay
- Fibroblast migration promoting activity
- Scratch assay
- EV potency testing
- EV marker profiling
- Cryo-EM
- Drug screening
- Toxicity studies
- Potency evaluation
- Functional testing
- Cell characterization
- Scale and capacity
- Cell factories for EV production
- Cell lines for EV production
- Therapeutic areas
- Biomedicine
- Biotechnology
- Toxicology
- Preclinical testing
Instruments and platforms
- Cryo-EM
- Organ-on-a-chip systems
- Microfluidic kits
- Nortis Inc. MPS
- Nikon application note
Modalities and species
- Modalities
- Gene editing
- Species and models
- Human
- Adipose tissue
- Bone marrow
- Colon
- Cornea
- Dental pulp
10 more
- Endometrium
- Kidney
- Lung
- Mammary gland
- Muscle
- Placenta
- Skin
- Thymus
- Umbilical cord
- Vascular system
Industries served
- Biomedicine
- Biotechnology
- Toxicology
- Preclinical testing
Details
- Quality
- Extended routine quality control systems · MISEV2023 criteria (extracellular vesicle characterization) · ethical approval and informed consent (tissue sourcing) · highest quality standards (cell line generation) · routine quality control systems (cell line development) · mycoplasma tests (included in all studies for personalized cell line development) · authentication (cell line development) · sterility tests (requested information for personalized cell line development)
- Address
- Leberstrasse 20 1110 Vienna Austria VAT: ATU66244913 office
- Phone
- +43 (0) 1 391 44 22